ALX Oncology Holdings Cash Flow Statement 2018-2024 | ALXO

Fifteen years of historical annual cash flow statements for ALX Oncology Holdings (ALXO).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-160.81$-123.48$-83.46$-45.74$-19.24$-13.73
$-5.40$-0.55$0.05$0.62$0.44$0.43
$27.55$24.96$19.34$6.58$0.30$0.27
$22.14$24.41$19.39$7.20$0.74$0.70
$0$0$0$0.54$0.40$-0.93
$0$0$0$0$0$0
$0.46$4.51$3.29$-3.74$2.98$-0.27
$-2.28$-1.70$-12.04$-1.53$0.75$1.03
$8.30$9.85$-4.03$0.25$4.26$-0.16
$-130.36$-89.22$-68.10$-38.29$-14.25$-13.19
$-1.27$-1.43$-4.92$-0.03$-0.35$-0.65
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$45.93$-233.99$0$0$0$0
$45.93$-233.99$0$0$0$0
$0$0$0$0.64$0$0
$44.66$-235.42$-4.92$0.61$-0.35$-0.65
$-0.39$9.61$-0.28$0$5.92$0
$0$0$0$0$0$0
$-0.39$9.61$-0.28$0$5.92$0
$59.68$0.90$2.75$369$0.01$0.01
$59.68$0.90$2.75$473$9.44$0.01
$0$0$0$0$0$0
$0$-0.66$0$-10.35$0$0
$59.29$9.86$2.47$463$15.36$0.00
$-26.42$-314.78$-70.55$425$0.76$-13.84
$26.27$23.84$13.91$5.44$0.30$0.27
$0$0$0$0$0$0